FibroGen, Inc.
CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR

Last updated:

Abstract:

The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.

Status:
Application
Type:

Utility

Filling date:

16 Dec 2019

Issue date:

16 Apr 2020